These key areas cover:
- Organization of the transition process including the integration of management functions.
- Implementation of the technology development programme involving electronic trading of IPE products.
- Development of clearing for OTC products which would utilize the clearing, settlement and netting facilities offered within the IPE's existing business structure.
- New product development taking maximum advantage of the synergies implicit in the new partnership.
- Expansion into targeted new markets, for example, Singapore and the Far East via ICE's new Singapore office.
"Given the overwhelming vote of confidence that our shareholders have just expressed, we believe there are great opportunities to expand both the product and geographical range of our new ventures," said Dr. Richard Ward. (It was reported yesterday that around 90% of IPE shareholders had tendered their shares to ICE.)